emergent surgery use -- off label use | PTLA Message Board Posts

Portola Pharmaceuticals, Inc.

  PTLA website

PTLA   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  6052 of 6324  at  3/10/2019 11:52:56 AM  by


 In response to msg 6051 by  watsonturtle
view thread

Re: emergent surgery use -- off label use

 With all due respect A will be "widely available" when they have it on all of the formularies for top tier trauma centers (600) and then the balance of the total of 1500 hospitals they are initially targeting.  They have quite some way to go.   Don't get me wrong I don't expect them to reach that overnight, but I do expect them to show significant quarter by quarter progress with no blips and to have at least the top tier 600 hospitals on board when they said they would.  I realize they are being purposely vague now about projections and I think that is prudent at this stage.  

It is clear that the company will be judged soley at this point on execution against A sales and investors will have little patience for the buffoonery of the pass!!

As far as the NTAP, my understanding is that it is an ADD on payment to the CMS reimbursement.   Thus total reimbursement.  Am I understanding this incorrectly?

I do believe A will be used off label and emergent surgery is clearly a warranted off label use.  That being said, IMHO I don't think off label use at this point will be significant. 

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 354
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
Financial Market Data provided by